Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ISRG NYSE:JNJ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$453.49+0.4%$472.19$427.84▼$603.88$159.99B1.512.27 million shs1.56 million shsJNJJohnson & Johnson$222.37-1.0%$237.59$146.12▼$251.71$540.71B0.277.81 million shs7.27 million shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical+0.08%-0.46%-0.19%-5.16%-14.84%JNJJohnson & Johnson-0.50%-1.24%-6.81%-5.55%+45.20%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$453.49+0.4%$472.19$427.84▼$603.88$159.99B1.512.27 million shs1.56 million shsJNJJohnson & Johnson$222.37-1.0%$237.59$146.12▼$251.71$540.71B0.277.81 million shs7.27 million shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical+0.08%-0.46%-0.19%-5.16%-14.84%JNJJohnson & Johnson-0.50%-1.24%-6.81%-5.55%+45.20%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceISRGIntuitive Surgical 2.65Moderate Buy$581.9128.32% UpsideJNJJohnson & Johnson 2.67Moderate Buy$252.4813.54% UpsideCurrent Analyst Ratings BreakdownLatest JNJ and ISRG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/24/2026JNJJohnson & Johnson Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B+) ➝ Buy (B)4/23/2026ISRGIntuitive Surgical BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOverweight$712.00 ➝ $651.004/22/2026ISRGIntuitive Surgical HSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$653.00 ➝ $604.004/22/2026ISRGIntuitive Surgical Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$575.00 ➝ $610.004/22/2026ISRGIntuitive Surgical The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$609.00 ➝ $621.004/22/2026ISRGIntuitive Surgical Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$560.00 ➝ $515.004/22/2026ISRGIntuitive Surgical Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$615.00 ➝ $577.004/22/2026ISRGIntuitive Surgical Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$622.00 ➝ $573.004/22/2026ISRGIntuitive Surgical JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$625.00 ➝ $550.004/22/2026ISRGIntuitive Surgical TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$660.00 ➝ $585.004/22/2026ISRGIntuitive Surgical Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$620.00 ➝ $580.00(Data available from 5/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookISRGIntuitive Surgical$10.06B15.96$9.32 per share48.65$49.69 per share9.13JNJJohnson & Johnson$96.36B5.56$13.92 per share15.97$33.73 per share6.59Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateISRGIntuitive Surgical$2.86B$8.2554.9746.233.6128.15%15.98%14.07%N/AJNJJohnson & Johnson$26.80B$8.6525.7117.682.2121.83%32.60%13.29%7/15/2026 (Estimated)Latest JNJ and ISRG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/21/2026Q1 2026ISRGIntuitive Surgical$2.08$2.50+$0.42$2.28$2.62 billion$2.77 billion4/14/2026Q1 2026JNJJohnson & Johnson$2.68$2.70+$0.02$2.14$23.60 billion$24.06 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthISRGIntuitive SurgicalN/AN/AN/AN/AN/AJNJJohnson & Johnson$5.362.41%+5.25%61.97%64 YearsLatest JNJ and ISRG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/14/2026JNJJohnson & Johnsonquarterly$1.342.23%5/26/20265/26/20266/9/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioISRGIntuitive SurgicalN/A4.613.59JNJJohnson & Johnson0.461.030.77Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipISRGIntuitive Surgical83.64%JNJJohnson & Johnson69.55%Insider OwnershipCompanyInsider OwnershipISRGIntuitive Surgical0.60%JNJJohnson & Johnson0.16%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableISRGIntuitive Surgical17,021354.16 million352.04 millionOptionableJNJJohnson & Johnson138,2002.41 billion2.40 billionOptionableJNJ and ISRG HeadlinesRecent News About These CompaniesDARZALEX royalties drive Genmab’s Q1 revenue higher amid expansion push4 hours ago | finance.yahoo.comWhy This Income Pro Likes Banks, Chip-Equipment Companies, and MoreMay 7 at 1:39 PM | finance.yahoo.comJohnson And Johnson Balances Mental Health Push With Mixed Pipeline OutlookMay 7 at 1:39 PM | finance.yahoo.comDarzalex, Erleada & New Drugs Keep J&J's Oncology Engine Charged in Q1May 7 at 12:46 PM | zacks.comThis Dividend Pro Likes Banks, Semi-Equipment Stocks, Altria, and J&JMay 7 at 11:34 AM | barrons.comJohnson & Johnson launches "Generation Fine," a New Movement Encouraging Patients to Expect More from Depression Treatment and Aim for RemissionMay 7 at 8:39 AM | finance.yahoo.comJohnson & Johnson launches "Generation Fine," a New Movement Encouraging Patients to Expect More from Depression Treatment and Aim for RemissionMay 7 at 8:00 AM | prnewswire.comPrincipal Financial Group Inc. Buys 28,370 Shares of Johnson & Johnson $JNJMay 7 at 6:00 AM | marketbeat.comQRG Capital Management Inc. Has $80.46 Million Stock Position in Johnson & Johnson $JNJMay 7 at 5:44 AM | marketbeat.comJohnson & Johnson $JNJ Shares Acquired by Truist Financial CorpMay 7 at 5:44 AM | marketbeat.comPeregrine Asset Advisers Inc. Boosts Stake in Johnson & Johnson $JNJMay 7 at 5:44 AM | marketbeat.comSafer Dividend King to Buy Now: AbbVie or Johnson & Johnson?May 6 at 5:37 PM | fool.comSafer Dividend King to Buy Now: AbbVie or Johnson & Johnson?May 6 at 4:31 PM | fool.comIs Johnson & Johnson Still the Ultimate Safe Dividend Stock to Buy?May 6 at 2:11 PM | fool.comJohnson & Johnson says Ottava surgical robot met endpoints in pivotal bariatric surgery studyMay 6 at 12:37 PM | massdevice.comJohnson & Johnson advances IBD therapy, despite trial missMay 6 at 12:37 PM | statnews.comSJohnson And Johnson Expands Clinical Pipeline In Immunology MedTech And AIMay 6 at 12:37 PM | finance.yahoo.com6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market CrashMay 6 at 12:37 PM | 247wallst.com6 Pharma Dividend Stocks Yielding Up to 6.44% — and They've Survived Every Market CrashMay 6 at 10:32 AM | 247wallst.comThese 3 Dividend Stocks Have Raised Their Payouts for a Combined 187 Years. Here's Why That Matters To Passive Income LoversMay 6 at 10:01 AM | 247wallst.comThese 3 Dividend Stocks Have Raised Their Payouts for a Combined 187 Years. Here's Why That Matters To Passive Income LoversMay 6 at 9:50 AM | 247wallst.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWith Nike Shares Near a 12-Year Low, Is Now the Time to Be Brave?By Sam Quirke | April 12, 20263 Dividend Aristocrats Whose Yields Can Help Combat InflationBy Chris Markoch | April 9, 2026The War Won't Last Forever: 3 Stocks That Could Lead the RecoveryBy Bridget Bennett | April 8, 2026Johnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings ResultsBy Thomas Hughes | April 14, 2026Intuitive Surgical's Selloff Sets Up a 30% Rebound OpportunityBy Thomas Hughes | April 23, 2026JNJ and ISRG Company DescriptionsIntuitive Surgical NASDAQ:ISRG$453.49 +1.76 (+0.39%) Closing price 04:00 PM EasternExtended Trading$453.08 -0.41 (-0.09%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.Johnson & Johnson NYSE:JNJ$222.37 -2.25 (-1.00%) Closing price 03:59 PM EasternExtended Trading$222.67 +0.29 (+0.13%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally IonQ Just Posted a Breakout Quarter—But 1 Problem Remains Super Micro Surges Over 20% as Margins Soar, Sales Fall Short Nuts and Bolts AI Play Gains Momentum: Astera Labs Targets Raised Anheuser-Busch Stock Jumps as Volume Growth Signals Turnaround Light Speed Returns: Corning Cashes In on NVIDIA Growth Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
